Asra R, Jones A
Toxicol Res (Camb). 2023; 12(2):150-177.
PMID: 37125339
PMC: 10141794.
DOI: 10.1093/toxres/tfad009.
Albuquerque R, Malcher N, Amado L, Coleman M, Dos Santos D, Borges R
PLoS One. 2015; 10(8):e0134768.
PMID: 26284371
PMC: 4540410.
DOI: 10.1371/journal.pone.0134768.
Wozel G, Blasum C
Arch Dermatol Res. 2013; 306(2):103-24.
PMID: 24310318
PMC: 3927068.
DOI: 10.1007/s00403-013-1409-7.
Bordin L, Fiore C, Zen F, Coleman M, Ragazzi E, Clari G
Br J Pharmacol. 2010; 161(5):1186-99.
PMID: 20662842
PMC: 2998697.
DOI: 10.1111/j.1476-5381.2010.00962.x.
Sharma A, Pilote S, Belanger P, Arsenault M, Hamelin B
Br J Clin Pharmacol. 2004; 58(3):288-97.
PMID: 15327588
PMC: 1884572.
DOI: 10.1111/j.1365-2125.2004.02162.x.
N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.
Gill H, Tingle M, Park B
Br J Clin Pharmacol. 1995; 40(6):531-8.
PMID: 8703658
PMC: 1365207.
DOI: 10.1111/j.1365-2125.1995.tb05797.x.
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
Ahmad R, Rogers H
Br J Clin Pharmacol. 1980; 10(5):519-24.
PMID: 7437265
PMC: 1430153.
DOI: 10.1111/j.1365-2125.1980.tb01798.x.
Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.
Ahmad R, Rogers H
Eur J Clin Pharmacol. 1980; 17(2):129-33.
PMID: 7371704
DOI: 10.1007/BF00562621.
Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.
Drayer D
Drugs. 1982; 24(6):519-42.
PMID: 6759093
DOI: 10.2165/00003495-198224060-00003.
Clinical pharmacokinetics of dapsone.
Zuidema J, Merkus F
Clin Pharmacokinet. 1986; 11(4):299-315.
PMID: 3530584
DOI: 10.2165/00003088-198611040-00003.
Clinical features and management of poisoning due to antimalarial drugs.
Jaeger A, Sauder P, Kopferschmitt J, Flesch F
Med Toxicol Adverse Drug Exp. 1987; 2(4):242-73.
PMID: 3306266
DOI: 10.1007/BF03259868.
Effect of cancer chemotherapy on dapsone N-acetylation in man.
Philip P, Harper P, Rogers H
Cancer Chemother Pharmacol. 1989; 23(6):395-6.
PMID: 2713961
DOI: 10.1007/BF00435844.
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
Coleman M, Breckenridge A, Park B
Br J Clin Pharmacol. 1989; 28(4):389-95.
PMID: 2590600
PMC: 1379987.
DOI: 10.1111/j.1365-2125.1989.tb03517.x.
An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
Tingle M, Coleman M, Park B
Br J Clin Pharmacol. 1990; 30(6):829-38.
PMID: 2288829
PMC: 1368303.
DOI: 10.1111/j.1365-2125.1990.tb05448.x.
The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Coleman M, Scott A, Breckenridge A, Park B
Br J Clin Pharmacol. 1990; 30(5):761-7.
PMID: 2271376
PMC: 1368178.
DOI: 10.1111/j.1365-2125.1990.tb03847.x.
Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.
Riley R, Roberts P, Coleman M, Kitteringham N, Park B
Br J Clin Pharmacol. 1990; 30(3):417-26.
PMID: 2223420
PMC: 1368145.
DOI: 10.1111/j.1365-2125.1990.tb03793.x.
The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
Tingle M, Coleman M, Park B
Br J Clin Pharmacol. 1991; 32(1):120-3.
PMID: 1888631
PMC: 1368503.
DOI: 10.1111/j.1365-2125.1991.tb05623.x.
The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Coleman M, Rhodes L, Scott A, Verbov J, Friedmann P, Breckenridge A
Br J Clin Pharmacol. 1992; 34(3):244-9.
PMID: 1389948
PMC: 1381395.
DOI: 10.1111/j.1365-2125.1992.tb04131.x.
Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulfone.
Goldstein B, McDonagh E
J Clin Invest. 1976; 57(5):1302-7.
PMID: 1262473
PMC: 436783.
DOI: 10.1172/JCI108398.
The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.
Allen B, Ellard G, Gammon P, King R, McDOUGALL A, Rees R
Br J Pharmacol. 1975; 55(1):151-5.
PMID: 1182342
PMC: 1666712.
DOI: 10.1111/j.1476-5381.1975.tb07623.x.
